circulating tumor DNA
Molecular Health, Eone-Diagnomics Genome Center Ink Liquid Biopsy Partnership
EDGC will use Molecular Health's genomics interpretation software to provide circulating tumor DNA sequencing test results for cancer precision medicine.
Delfi Diagnostics Tags Lung Cancer as First Target for Fragmentation-Based Liquid Biopsy Tech
Premium
Based on promising early results, the company is now conducting a larger case-control study to lock in a classifier for prospective validation in an intended-use population.
Guardant Health Q2 Revenues Grow 39 Percent
The firm's oncology testing revenues outpaced other revenue sources, driven by a more than 50 percent increase in clinical test volume.
TwinStrand Biosciences Sues Guardant Health for Alleged Patent Infringement
The company argued in its complaint that Guardant's liquid biopsy assays have willfully infringed its patented duplex sequencing technology.
Genetron Health Partners with Guizhou Local Government for Liver Cancer Early Screening Project
The firm will provide testing using its HCCscreen assay and help develop follow-up procedures as part of an effort to advance cancer early detection in rural areas of China.